| __timestamp | BioCryst Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 1488000000 |
| Thursday, January 1, 2015 | 72758000 | 1525000000 |
| Friday, January 1, 2016 | 61008000 | 2111000000 |
| Sunday, January 1, 2017 | 66962000 | 1848000000 |
| Monday, January 1, 2018 | 84888000 | 1213000000 |
| Tuesday, January 1, 2019 | 107068000 | 1010000000 |
| Wednesday, January 1, 2020 | 122964000 | 997000000 |
| Friday, January 1, 2021 | 208808000 | 967000000 |
| Saturday, January 1, 2022 | 253297000 | 838000000 |
| Sunday, January 1, 2023 | 216566000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Unleashing the power of data
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Teva Pharmaceutical Industries Limited and BioCryst Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment.
Teva, a global leader, has consistently invested heavily in R&D, with expenditures peaking in 2016 at over 2 billion dollars. However, their spending has seen a gradual decline, dropping by approximately 55% by 2023. In contrast, BioCryst, a smaller player, has shown a remarkable upward trend, increasing its R&D spending by over 300% from 2014 to 2023. This strategic focus on innovation has positioned BioCryst as a rising star in the industry.
These trends highlight the dynamic nature of pharmaceutical innovation, where strategic investment in R&D can redefine a company's trajectory.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Ascendis Pharma A/S vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: MannKind Corporation vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Celldex Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.